← Evidence map

ArticleFrontiers in medicine2025

Implementation of a quality management system for decentralized manufacturing of cell and gene therapy products - technical and regulatory considerations.

Heiko von der Leyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40837571